Insiders · Profile

Khosla Rachna

SVP, Business Development at Amgen. Filing since 9 Nov 2022. CIK 0001881332

Company

Date

Role

Action

Amount

Of holding

13 Aug 2026

SVP, Business Development

Sold at will

1,252

$521.36K

16.4%

11 Aug 2026

SVP, Business Development

Sold at will

2,000

$825.13K

23.8%

12 Nov 2025

SVP, Business Development

Sold at will

890

$299.26K

11.2%

5 Jun 2025

SVP, Business Development

Sold at will

1,500

$434.52K

15.5%

9 Nov 2022

SVP, Business Development

Sold, plan not stated

387

$113.35K

5.5%

5 decisions on file.